Clinical Trials Browser

Interventional × Pituitary ACTH Hypersecretion × 1 year × Clear all

NCT03604198 2026-04-21

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT04569591 2026-04-09

DDAVP for Pituitary Adenoma

Phase NA Recruiting

22 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Phase EARLY_PHASE1 Not yet recruiting

50 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT05307328 2025-10-08

RESCUE

Phase 2 Completed

26 enrolled

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT03697109 2025-07-16

GRACE

Phase 3 Completed

152 enrolled 28 charts

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Pituitary ACTH Hypersecretion

NCT05971758 2025-07-04

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

Phase 2 Recruiting

20 enrolled

Endocrine

Pituitary ACTH Hypersecretion